nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—osteoarthritis—Prednisone—hematologic cancer	0.337	1	CpDpCtD
Oxaprozin—PTGS2—Lenalidomide—hematologic cancer	0.0651	0.152	CbGbCtD
Oxaprozin—PTGS2—Thalidomide—hematologic cancer	0.0348	0.0813	CbGbCtD
Oxaprozin—PTGS1—Bortezomib—hematologic cancer	0.0337	0.0788	CbGbCtD
Oxaprozin—PTGS1—Thalidomide—hematologic cancer	0.0294	0.0686	CbGbCtD
Oxaprozin—PTGS1—Ifosfamide—hematologic cancer	0.0258	0.0604	CbGbCtD
Oxaprozin—PTGS1—Imatinib—hematologic cancer	0.0247	0.0577	CbGbCtD
Oxaprozin—PTGS2—Triamcinolone—hematologic cancer	0.0241	0.0563	CbGbCtD
Oxaprozin—CYP2C9—Bexarotene—hematologic cancer	0.0221	0.0517	CbGbCtD
Oxaprozin—PTGS2—Betamethasone—hematologic cancer	0.0207	0.0483	CbGbCtD
Oxaprozin—CYP2C9—Idarubicin—hematologic cancer	0.0183	0.0429	CbGbCtD
Oxaprozin—PTGS2—Cisplatin—hematologic cancer	0.0149	0.0348	CbGbCtD
Oxaprozin—PTGS2—Etoposide—hematologic cancer	0.0146	0.0342	CbGbCtD
Oxaprozin—CYP2C9—Bortezomib—hematologic cancer	0.0136	0.0317	CbGbCtD
Oxaprozin—PTGS1—Etoposide—hematologic cancer	0.0124	0.0289	CbGbCtD
Oxaprozin—PTGS2—Dexamethasone—hematologic cancer	0.012	0.0281	CbGbCtD
Oxaprozin—CYP2C9—Thalidomide—hematologic cancer	0.0118	0.0276	CbGbCtD
Oxaprozin—CYP2C9—Teniposide—hematologic cancer	0.0113	0.0264	CbGbCtD
Oxaprozin—CYP2C9—Ifosfamide—hematologic cancer	0.0104	0.0243	CbGbCtD
Oxaprozin—CYP2C9—Imatinib—hematologic cancer	0.00994	0.0232	CbGbCtD
Oxaprozin—CYP2C9—Nilotinib—hematologic cancer	0.00903	0.0211	CbGbCtD
Oxaprozin—CYP2C9—Cisplatin—hematologic cancer	0.00506	0.0118	CbGbCtD
Oxaprozin—CYP2C9—Dexamethasone—hematologic cancer	0.00409	0.00956	CbGbCtD
Oxaprozin—PTGS2—ovarian follicle—hematologic cancer	0.00327	0.493	CbGeAlD
Oxaprozin—CYP2C9—hematopoietic system—hematologic cancer	0.000453	0.0682	CbGeAlD
Oxaprozin—PTGS1—hematopoietic system—hematologic cancer	0.000413	0.0622	CbGeAlD
Oxaprozin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000397	0.209	CbGdCrCtD
Oxaprozin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000397	0.209	CbGdCrCtD
Oxaprozin—PTGS2—hematopoietic system—hematologic cancer	0.000395	0.0595	CbGeAlD
Oxaprozin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000388	0.205	CbGdCrCtD
Oxaprozin—CYP2C9—blood—hematologic cancer	0.0003	0.0452	CbGeAlD
Oxaprozin—PTGS1—blood—hematologic cancer	0.000274	0.0412	CbGeAlD
Oxaprozin—PTGS2—blood—hematologic cancer	0.000262	0.0394	CbGeAlD
Oxaprozin—PTGS2—bone marrow—hematologic cancer	0.000253	0.0381	CbGeAlD
Oxaprozin—PTGS1—lung—hematologic cancer	0.00024	0.0362	CbGeAlD
Oxaprozin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00024	0.126	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00024	0.126	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000234	0.124	CbGdCrCtD
Oxaprozin—PTGS2—lung—hematologic cancer	0.00023	0.0346	CbGeAlD
Oxaprozin—PTGS1—testis—hematologic cancer	0.000227	0.0341	CbGeAlD
Oxaprozin—Flurbiprofen—UGT1A1—hematologic cancer	0.000173	0.292	CrCbGaD
Oxaprozin—PTGS1—lymph node—hematologic cancer	0.000164	0.0247	CbGeAlD
Oxaprozin—PTGS2—lymph node—hematologic cancer	0.000157	0.0236	CbGeAlD
Oxaprozin—Diphenhydramine—SLC22A1—hematologic cancer	9.29e-05	0.157	CrCbGaD
Oxaprozin—Phenprocoumon—ALB—hematologic cancer	5.61e-05	0.0946	CrCbGaD
Oxaprozin—Warfarin—ALB—hematologic cancer	4.97e-05	0.0839	CrCbGaD
Oxaprozin—Propafenone—ABCB1—hematologic cancer	4.64e-05	0.0783	CrCbGaD
Oxaprozin—Flurbiprofen—ALB—hematologic cancer	4.24e-05	0.0716	CrCbGaD
Oxaprozin—Phenytoin—ALB—hematologic cancer	3.61e-05	0.061	CrCbGaD
Oxaprozin—Carbamazepine—ABCB1—hematologic cancer	3.55e-05	0.0599	CrCbGaD
Oxaprozin—Phenytoin—ABCB1—hematologic cancer	3.45e-05	0.0582	CrCbGaD
Oxaprozin—Methadone—ABCB1—hematologic cancer	2.61e-05	0.044	CrCbGaD
Oxaprozin—Headache—Irinotecan—hematologic cancer	2.36e-05	0.000126	CcSEcCtD
Oxaprozin—Nausea—Ifosfamide—hematologic cancer	2.36e-05	0.000125	CcSEcCtD
Oxaprozin—Feeling abnormal—Triamcinolone—hematologic cancer	2.35e-05	0.000125	CcSEcCtD
Oxaprozin—Diarrhoea—Cisplatin—hematologic cancer	2.34e-05	0.000125	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Anxiety—Prednisone—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Vomiting—Gemcitabine—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Insomnia—Betamethasone—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Insomnia—Dexamethasone—hematologic cancer	2.34e-05	0.000124	CcSEcCtD
Oxaprozin—Paraesthesia—Dexamethasone—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Oxaprozin—Paraesthesia—Betamethasone—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Oxaprozin—Discomfort—Prednisone—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Oxaprozin—Rash—Gemcitabine—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Oxaprozin—Dermatitis—Gemcitabine—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—hematologic cancer	2.31e-05	0.000123	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—hematologic cancer	2.3e-05	0.000122	CcSEcCtD
Oxaprozin—Headache—Gemcitabine—hematologic cancer	2.3e-05	0.000122	CcSEcCtD
Oxaprozin—Nausea—Vincristine—hematologic cancer	2.3e-05	0.000122	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—hematologic cancer	2.29e-05	0.000122	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—hematologic cancer	2.29e-05	0.000122	CcSEcCtD
Oxaprozin—Dyspepsia—Dexamethasone—hematologic cancer	2.27e-05	0.000121	CcSEcCtD
Oxaprozin—Dyspepsia—Betamethasone—hematologic cancer	2.27e-05	0.000121	CcSEcCtD
Oxaprozin—Urticaria—Triamcinolone—hematologic cancer	2.26e-05	0.00012	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—hematologic cancer	2.26e-05	0.00012	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—hematologic cancer	2.25e-05	0.00012	CcSEcCtD
Oxaprozin—Body temperature increased—Triamcinolone—hematologic cancer	2.25e-05	0.00012	CcSEcCtD
Oxaprozin—Oedema—Prednisone—hematologic cancer	2.25e-05	0.00012	CcSEcCtD
Oxaprozin—Anaphylactic shock—Prednisone—hematologic cancer	2.25e-05	0.00012	CcSEcCtD
Oxaprozin—Decreased appetite—Betamethasone—hematologic cancer	2.25e-05	0.000119	CcSEcCtD
Oxaprozin—Decreased appetite—Dexamethasone—hematologic cancer	2.25e-05	0.000119	CcSEcCtD
Oxaprozin—Nausea—Mitoxantrone—hematologic cancer	2.24e-05	0.000119	CcSEcCtD
Oxaprozin—Nausea—Irinotecan—hematologic cancer	2.24e-05	0.000119	CcSEcCtD
Oxaprozin—Infection—Prednisone—hematologic cancer	2.24e-05	0.000119	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—hematologic cancer	2.22e-05	0.000118	CcSEcCtD
Oxaprozin—Shock—Prednisone—hematologic cancer	2.21e-05	0.000118	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—hematologic cancer	2.21e-05	0.000118	CcSEcCtD
Oxaprozin—Tachycardia—Prednisone—hematologic cancer	2.2e-05	0.000117	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—hematologic cancer	2.19e-05	0.000116	CcSEcCtD
Oxaprozin—Nausea—Gemcitabine—hematologic cancer	2.18e-05	0.000116	CcSEcCtD
Oxaprozin—Vomiting—Cisplatin—hematologic cancer	2.18e-05	0.000116	CcSEcCtD
Oxaprozin—Hyperhidrosis—Prednisone—hematologic cancer	2.18e-05	0.000116	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—hematologic cancer	2.17e-05	0.000115	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—hematologic cancer	2.17e-05	0.000115	CcSEcCtD
Oxaprozin—Rash—Cisplatin—hematologic cancer	2.16e-05	0.000115	CcSEcCtD
Oxaprozin—Dermatitis—Cisplatin—hematologic cancer	2.16e-05	0.000115	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—hematologic cancer	2.15e-05	0.000114	CcSEcCtD
Oxaprozin—Anorexia—Prednisone—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—hematologic cancer	2.13e-05	0.000113	CcSEcCtD
Oxaprozin—Feeling abnormal—Dexamethasone—hematologic cancer	2.13e-05	0.000113	CcSEcCtD
Oxaprozin—Feeling abnormal—Betamethasone—hematologic cancer	2.13e-05	0.000113	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—hematologic cancer	2.12e-05	0.000113	CcSEcCtD
Oxaprozin—Tension—Epirubicin—hematologic cancer	2.12e-05	0.000112	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.11e-05	0.000112	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.11e-05	0.000112	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—hematologic cancer	2.11e-05	0.000112	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—hematologic cancer	2.09e-05	0.000111	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—hematologic cancer	2.08e-05	0.00011	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—hematologic cancer	2.08e-05	0.00011	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—hematologic cancer	2.07e-05	0.00011	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—hematologic cancer	2.06e-05	0.00011	CcSEcCtD
Oxaprozin—Urticaria—Dexamethasone—hematologic cancer	2.05e-05	0.000109	CcSEcCtD
Oxaprozin—Urticaria—Betamethasone—hematologic cancer	2.05e-05	0.000109	CcSEcCtD
Oxaprozin—Dizziness—Prednisolone—hematologic cancer	2.05e-05	0.000109	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—hematologic cancer	2.05e-05	0.000109	CcSEcCtD
Oxaprozin—Asthenia—Triamcinolone—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Oxaprozin—Abdominal pain—Betamethasone—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Oxaprozin—Abdominal pain—Dexamethasone—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Oxaprozin—Body temperature increased—Dexamethasone—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Oxaprozin—Body temperature increased—Betamethasone—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Oxaprozin—Nausea—Cisplatin—hematologic cancer	2.04e-05	0.000108	CcSEcCtD
Oxaprozin—Insomnia—Prednisone—hematologic cancer	2.04e-05	0.000108	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—hematologic cancer	2.03e-05	0.000108	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—hematologic cancer	2.03e-05	0.000108	CcSEcCtD
Oxaprozin—Paraesthesia—Prednisone—hematologic cancer	2.02e-05	0.000107	CcSEcCtD
Oxaprozin—Pruritus—Triamcinolone—hematologic cancer	2.01e-05	0.000107	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—hematologic cancer	2e-05	0.000106	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—hematologic cancer	2e-05	0.000106	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—hematologic cancer	2e-05	0.000106	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—hematologic cancer	1.99e-05	0.000106	CcSEcCtD
Oxaprozin—Dyspepsia—Prednisone—hematologic cancer	1.98e-05	0.000105	CcSEcCtD
Oxaprozin—Rash—Etoposide—hematologic cancer	1.98e-05	0.000105	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—hematologic cancer	1.98e-05	0.000105	CcSEcCtD
Oxaprozin—Headache—Etoposide—hematologic cancer	1.97e-05	0.000105	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—hematologic cancer	1.97e-05	0.000104	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—hematologic cancer	1.96e-05	0.000104	CcSEcCtD
Oxaprozin—Decreased appetite—Prednisone—hematologic cancer	1.96e-05	0.000104	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Oxaprozin—Rash—Prednisolone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Oxaprozin—Dermatitis—Prednisolone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—hematologic cancer	1.94e-05	0.000103	CcSEcCtD
Oxaprozin—Headache—Prednisolone—hematologic cancer	1.94e-05	0.000103	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—hematologic cancer	1.94e-05	0.000103	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—hematologic cancer	1.94e-05	0.000103	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—hematologic cancer	1.94e-05	0.000103	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—hematologic cancer	1.93e-05	0.000103	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—hematologic cancer	1.93e-05	0.000103	CcSEcCtD
Oxaprozin—Constipation—Prednisone—hematologic cancer	1.92e-05	0.000102	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—hematologic cancer	1.91e-05	0.000101	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—hematologic cancer	1.9e-05	0.000101	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—hematologic cancer	1.9e-05	0.000101	CcSEcCtD
Oxaprozin—Dizziness—Triamcinolone—hematologic cancer	1.88e-05	0.0001	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—hematologic cancer	1.88e-05	9.99e-05	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—hematologic cancer	1.88e-05	9.99e-05	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—hematologic cancer	1.87e-05	9.93e-05	CcSEcCtD
Oxaprozin—Infection—Methotrexate—hematologic cancer	1.87e-05	9.93e-05	CcSEcCtD
Oxaprozin—Nausea—Etoposide—hematologic cancer	1.86e-05	9.91e-05	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—hematologic cancer	1.86e-05	9.89e-05	CcSEcCtD
Oxaprozin—Feeling abnormal—Prednisone—hematologic cancer	1.85e-05	9.85e-05	CcSEcCtD
Oxaprozin—Asthenia—Betamethasone—hematologic cancer	1.85e-05	9.85e-05	CcSEcCtD
Oxaprozin—Asthenia—Dexamethasone—hematologic cancer	1.85e-05	9.85e-05	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.85e-05	9.84e-05	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—hematologic cancer	1.84e-05	9.8e-05	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—hematologic cancer	1.84e-05	9.78e-05	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Prednisone—hematologic cancer	1.84e-05	9.78e-05	CcSEcCtD
Oxaprozin—Nausea—Prednisolone—hematologic cancer	1.84e-05	9.77e-05	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—hematologic cancer	1.83e-05	9.72e-05	CcSEcCtD
Oxaprozin—Pruritus—Betamethasone—hematologic cancer	1.83e-05	9.71e-05	CcSEcCtD
Oxaprozin—Pruritus—Dexamethasone—hematologic cancer	1.83e-05	9.71e-05	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—hematologic cancer	1.82e-05	9.66e-05	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—hematologic cancer	1.81e-05	9.64e-05	CcSEcCtD
Oxaprozin—Vomiting—Triamcinolone—hematologic cancer	1.81e-05	9.62e-05	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—hematologic cancer	1.8e-05	9.56e-05	CcSEcCtD
Oxaprozin—Rash—Triamcinolone—hematologic cancer	1.8e-05	9.54e-05	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—hematologic cancer	1.8e-05	9.54e-05	CcSEcCtD
Oxaprozin—Dermatitis—Triamcinolone—hematologic cancer	1.79e-05	9.53e-05	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—hematologic cancer	1.79e-05	9.53e-05	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—hematologic cancer	1.79e-05	9.53e-05	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—hematologic cancer	1.79e-05	9.51e-05	CcSEcCtD
Oxaprozin—Urticaria—Prednisone—hematologic cancer	1.79e-05	9.5e-05	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—hematologic cancer	1.79e-05	9.49e-05	CcSEcCtD
Oxaprozin—Headache—Triamcinolone—hematologic cancer	1.78e-05	9.48e-05	CcSEcCtD
Oxaprozin—Abdominal pain—Prednisone—hematologic cancer	1.78e-05	9.45e-05	CcSEcCtD
Oxaprozin—Body temperature increased—Prednisone—hematologic cancer	1.78e-05	9.45e-05	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—hematologic cancer	1.77e-05	9.43e-05	CcSEcCtD
Oxaprozin—Diarrhoea—Dexamethasone—hematologic cancer	1.77e-05	9.39e-05	CcSEcCtD
Oxaprozin—Diarrhoea—Betamethasone—hematologic cancer	1.77e-05	9.39e-05	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—hematologic cancer	1.76e-05	9.37e-05	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—hematologic cancer	1.76e-05	9.35e-05	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—hematologic cancer	1.76e-05	9.35e-05	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—hematologic cancer	1.76e-05	9.34e-05	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—hematologic cancer	1.75e-05	9.32e-05	CcSEcCtD
Oxaprozin—Infection—Epirubicin—hematologic cancer	1.75e-05	9.29e-05	CcSEcCtD
Oxaprozin—Shock—Epirubicin—hematologic cancer	1.73e-05	9.2e-05	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—hematologic cancer	1.73e-05	9.19e-05	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—hematologic cancer	1.72e-05	9.16e-05	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—hematologic cancer	1.72e-05	9.15e-05	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—hematologic cancer	1.72e-05	9.13e-05	CcSEcCtD
Oxaprozin—Dizziness—Dexamethasone—hematologic cancer	1.71e-05	9.08e-05	CcSEcCtD
Oxaprozin—Dizziness—Betamethasone—hematologic cancer	1.71e-05	9.08e-05	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—hematologic cancer	1.7e-05	9.04e-05	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—hematologic cancer	1.7e-05	9.04e-05	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—hematologic cancer	1.69e-05	9e-05	CcSEcCtD
Oxaprozin—Nausea—Triamcinolone—hematologic cancer	1.69e-05	8.99e-05	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—hematologic cancer	1.69e-05	8.97e-05	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—hematologic cancer	1.68e-05	8.92e-05	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—hematologic cancer	1.68e-05	8.91e-05	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—hematologic cancer	1.68e-05	8.91e-05	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—hematologic cancer	1.67e-05	8.88e-05	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—hematologic cancer	1.66e-05	8.83e-05	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—hematologic cancer	1.66e-05	8.8e-05	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—hematologic cancer	1.64e-05	8.74e-05	CcSEcCtD
Oxaprozin—Vomiting—Betamethasone—hematologic cancer	1.64e-05	8.73e-05	CcSEcCtD
Oxaprozin—Vomiting—Dexamethasone—hematologic cancer	1.64e-05	8.73e-05	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—hematologic cancer	1.64e-05	8.72e-05	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—hematologic cancer	1.63e-05	8.69e-05	CcSEcCtD
Oxaprozin—Rash—Dexamethasone—hematologic cancer	1.63e-05	8.66e-05	CcSEcCtD
Oxaprozin—Rash—Betamethasone—hematologic cancer	1.63e-05	8.66e-05	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—hematologic cancer	1.63e-05	8.65e-05	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.63e-05	8.65e-05	CcSEcCtD
Oxaprozin—Dermatitis—Dexamethasone—hematologic cancer	1.63e-05	8.65e-05	CcSEcCtD
Oxaprozin—Dermatitis—Betamethasone—hematologic cancer	1.63e-05	8.65e-05	CcSEcCtD
Oxaprozin—Headache—Dexamethasone—hematologic cancer	1.62e-05	8.6e-05	CcSEcCtD
Oxaprozin—Headache—Betamethasone—hematologic cancer	1.62e-05	8.6e-05	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—hematologic cancer	1.62e-05	8.6e-05	CcSEcCtD
Oxaprozin—Asthenia—Prednisone—hematologic cancer	1.61e-05	8.58e-05	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—hematologic cancer	1.6e-05	8.51e-05	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.59e-05	8.47e-05	CcSEcCtD
Oxaprozin—Pruritus—Prednisone—hematologic cancer	1.59e-05	8.46e-05	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—hematologic cancer	1.59e-05	8.46e-05	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—hematologic cancer	1.59e-05	8.45e-05	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—hematologic cancer	1.58e-05	8.4e-05	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.57e-05	8.37e-05	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—hematologic cancer	1.57e-05	8.34e-05	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—hematologic cancer	1.56e-05	8.31e-05	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—hematologic cancer	1.55e-05	8.25e-05	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—hematologic cancer	1.55e-05	8.23e-05	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—hematologic cancer	1.55e-05	8.23e-05	CcSEcCtD
Oxaprozin—Diarrhoea—Prednisone—hematologic cancer	1.54e-05	8.18e-05	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.54e-05	8.17e-05	CcSEcCtD
Oxaprozin—Nausea—Betamethasone—hematologic cancer	1.53e-05	8.16e-05	CcSEcCtD
Oxaprozin—Nausea—Dexamethasone—hematologic cancer	1.53e-05	8.16e-05	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—hematologic cancer	1.53e-05	8.13e-05	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—hematologic cancer	1.52e-05	8.09e-05	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—hematologic cancer	1.51e-05	8e-05	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—hematologic cancer	1.49e-05	7.94e-05	CcSEcCtD
Oxaprozin—Dizziness—Prednisone—hematologic cancer	1.49e-05	7.91e-05	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—hematologic cancer	1.49e-05	7.9e-05	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—hematologic cancer	1.49e-05	7.9e-05	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—hematologic cancer	1.47e-05	7.83e-05	CcSEcCtD
Oxaprozin—CYP2C9—Metabolism—HDC—hematologic cancer	1.47e-05	0.000391	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IDH1—hematologic cancer	1.47e-05	0.00039	CbGpPWpGaD
Oxaprozin—Paraesthesia—Doxorubicin—hematologic cancer	1.46e-05	7.77e-05	CcSEcCtD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	1.46e-05	0.000388	CbGpPWpGaD
Oxaprozin—Dyspnoea—Doxorubicin—hematologic cancer	1.45e-05	7.71e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—GSTO1—hematologic cancer	1.45e-05	0.000386	CbGpPWpGaD
Oxaprozin—Feeling abnormal—Epirubicin—hematologic cancer	1.45e-05	7.71e-05	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—hematologic cancer	1.45e-05	7.69e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—UGT1A1—hematologic cancer	1.44e-05	0.000383	CbGpPWpGaD
Oxaprozin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.44e-05	7.65e-05	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.43e-05	0.000381	CbGpPWpGaD
Oxaprozin—Dyspepsia—Doxorubicin—hematologic cancer	1.43e-05	7.62e-05	CcSEcCtD
Oxaprozin—Vomiting—Prednisone—hematologic cancer	1.43e-05	7.6e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—HMMR—hematologic cancer	1.43e-05	0.00038	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—IDH2—hematologic cancer	1.43e-05	0.00038	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AGO2—hematologic cancer	1.42e-05	0.000378	CbGpPWpGaD
Oxaprozin—Rash—Prednisone—hematologic cancer	1.42e-05	7.54e-05	CcSEcCtD
Oxaprozin—Dermatitis—Prednisone—hematologic cancer	1.42e-05	7.53e-05	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—hematologic cancer	1.42e-05	7.52e-05	CcSEcCtD
Oxaprozin—Headache—Prednisone—hematologic cancer	1.41e-05	7.49e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—HDAC9—hematologic cancer	1.41e-05	0.000374	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CRABP1—hematologic cancer	1.4e-05	0.000373	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC22A1—hematologic cancer	1.4e-05	0.000373	CbGpPWpGaD
Oxaprozin—Urticaria—Epirubicin—hematologic cancer	1.4e-05	7.43e-05	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—hematologic cancer	1.39e-05	7.4e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—H3F3B—hematologic cancer	1.39e-05	0.00037	CbGpPWpGaD
Oxaprozin—Abdominal pain—Epirubicin—hematologic cancer	1.39e-05	7.39e-05	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—hematologic cancer	1.39e-05	7.39e-05	CcSEcCtD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.37e-05	0.000364	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALOX5—hematologic cancer	1.36e-05	0.000363	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.36e-05	0.000361	CbGpPWpGaD
Oxaprozin—Asthenia—Methotrexate—hematologic cancer	1.35e-05	7.17e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.35e-05	0.000359	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ARNTL—hematologic cancer	1.34e-05	0.000358	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CDA—hematologic cancer	1.34e-05	0.000357	CbGpPWpGaD
Oxaprozin—Feeling abnormal—Doxorubicin—hematologic cancer	1.34e-05	7.13e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—NPM1—hematologic cancer	1.34e-05	0.000356	CbGpPWpGaD
Oxaprozin—Nausea—Prednisone—hematologic cancer	1.34e-05	7.1e-05	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.33e-05	7.08e-05	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—hematologic cancer	1.33e-05	7.07e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—NUP98—hematologic cancer	1.32e-05	0.000352	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.32e-05	0.000351	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.32e-05	0.00035	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACP5—hematologic cancer	1.31e-05	0.000348	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CA9—hematologic cancer	1.31e-05	0.000348	CbGpPWpGaD
Oxaprozin—Urticaria—Doxorubicin—hematologic cancer	1.29e-05	6.87e-05	CcSEcCtD
Oxaprozin—CYP2C9—Metabolism—PC—hematologic cancer	1.29e-05	0.000344	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOR2—hematologic cancer	1.29e-05	0.000343	CbGpPWpGaD
Oxaprozin—Body temperature increased—Doxorubicin—hematologic cancer	1.29e-05	6.84e-05	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—hematologic cancer	1.29e-05	6.84e-05	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—hematologic cancer	1.29e-05	6.84e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—ADCY7—hematologic cancer	1.28e-05	0.000341	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA3—hematologic cancer	1.28e-05	0.000341	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF19—hematologic cancer	1.28e-05	0.000341	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NUP214—hematologic cancer	1.27e-05	0.000339	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPS14—hematologic cancer	1.27e-05	0.000339	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—DKK1—hematologic cancer	1.26e-05	0.000336	CbGpPWpGaD
Oxaprozin—Asthenia—Epirubicin—hematologic cancer	1.26e-05	6.71e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.26e-05	0.000335	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT5B—hematologic cancer	1.25e-05	0.000333	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NUP98—hematologic cancer	1.25e-05	0.000333	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GBA—hematologic cancer	1.25e-05	0.000332	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.25e-05	0.000332	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCG2—hematologic cancer	1.25e-05	0.000332	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTR—hematologic cancer	1.25e-05	0.000332	CbGpPWpGaD
Oxaprozin—Pruritus—Epirubicin—hematologic cancer	1.25e-05	6.62e-05	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—hematologic cancer	1.24e-05	6.61e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—IDH1—hematologic cancer	1.23e-05	0.000327	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.23e-05	0.000327	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CST3—hematologic cancer	1.23e-05	0.000326	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ENO2—hematologic cancer	1.22e-05	0.000326	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.22e-05	0.000324	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADCY7—hematologic cancer	1.22e-05	0.000324	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCC3—hematologic cancer	1.22e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TXN—hematologic cancer	1.22e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTO1—hematologic cancer	1.22e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NUP214—hematologic cancer	1.21e-05	0.000321	CbGpPWpGaD
Oxaprozin—Diarrhoea—Epirubicin—hematologic cancer	1.2e-05	6.4e-05	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—hematologic cancer	1.2e-05	6.35e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—SPHK1—hematologic cancer	1.19e-05	0.000316	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTT1—hematologic cancer	1.19e-05	0.000316	CbGpPWpGaD
Oxaprozin—Rash—Methotrexate—hematologic cancer	1.19e-05	6.3e-05	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—hematologic cancer	1.18e-05	6.29e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—MTR—hematologic cancer	1.18e-05	0.000315	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—XIAP—hematologic cancer	1.18e-05	0.000315	CbGpPWpGaD
Oxaprozin—Headache—Methotrexate—hematologic cancer	1.18e-05	6.26e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.17e-05	0.000311	CbGpPWpGaD
Oxaprozin—Asthenia—Doxorubicin—hematologic cancer	1.17e-05	6.21e-05	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—hematologic cancer	1.16e-05	6.18e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—SDC1—hematologic cancer	1.16e-05	0.000309	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ENO2—hematologic cancer	1.16e-05	0.000309	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SMARCA4—hematologic cancer	1.15e-05	0.000307	CbGpPWpGaD
Oxaprozin—Pruritus—Doxorubicin—hematologic cancer	1.15e-05	6.12e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.14e-05	0.000304	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTAP—hematologic cancer	1.14e-05	0.000304	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.12e-05	0.000298	CbGpPWpGaD
Oxaprozin—Vomiting—Epirubicin—hematologic cancer	1.12e-05	5.95e-05	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—hematologic cancer	1.12e-05	5.94e-05	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—hematologic cancer	1.11e-05	5.92e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.11e-05	0.000296	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CRABP1—hematologic cancer	1.11e-05	0.000296	CbGpPWpGaD
Oxaprozin—Rash—Epirubicin—hematologic cancer	1.11e-05	5.9e-05	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—hematologic cancer	1.11e-05	5.89e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.11e-05	0.000295	CbGpPWpGaD
Oxaprozin—Headache—Epirubicin—hematologic cancer	1.1e-05	5.86e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—SDC1—hematologic cancer	1.1e-05	0.000293	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.09e-05	0.000291	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALOX5—hematologic cancer	1.08e-05	0.000288	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.08e-05	0.000288	CbGpPWpGaD
Oxaprozin—Dizziness—Doxorubicin—hematologic cancer	1.08e-05	5.72e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—LCK—hematologic cancer	1.07e-05	0.000283	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NUP98—hematologic cancer	1.05e-05	0.000279	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.05e-05	0.000278	CbGpPWpGaD
Oxaprozin—Nausea—Epirubicin—hematologic cancer	1.05e-05	5.55e-05	CcSEcCtD
Oxaprozin—PTGS2—Disease—H3F3A—hematologic cancer	1.04e-05	0.000278	CbGpPWpGaD
Oxaprozin—Vomiting—Doxorubicin—hematologic cancer	1.04e-05	5.5e-05	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—hematologic cancer	1.03e-05	5.46e-05	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—hematologic cancer	1.03e-05	5.45e-05	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—hematologic cancer	1.02e-05	5.42e-05	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—ADCY7—hematologic cancer	1.02e-05	0.000271	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA3—hematologic cancer	1.02e-05	0.000271	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FHL2—hematologic cancer	1.02e-05	0.000271	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCZ—hematologic cancer	1.02e-05	0.00027	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NUP214—hematologic cancer	1.01e-05	0.000269	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1e-05	0.000266	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AGRN—hematologic cancer	9.99e-06	0.000266	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALR—hematologic cancer	9.97e-06	0.000265	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTR—hematologic cancer	9.91e-06	0.000264	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG2—hematologic cancer	9.91e-06	0.000264	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CD44—hematologic cancer	9.87e-06	0.000262	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NQO1—hematologic cancer	9.87e-06	0.000262	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PARP1—hematologic cancer	9.8e-06	0.000261	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ENO2—hematologic cancer	9.72e-06	0.000258	CbGpPWpGaD
Oxaprozin—Nausea—Doxorubicin—hematologic cancer	9.67e-06	5.14e-05	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.66e-06	0.000257	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FBXW7—hematologic cancer	9.65e-06	0.000257	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMMR—hematologic cancer	9.47e-06	0.000252	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH2—hematologic cancer	9.47e-06	0.000252	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HDAC2—hematologic cancer	9.46e-06	0.000252	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CXCR4—hematologic cancer	9.46e-06	0.000252	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—hematologic cancer	9.43e-06	0.000251	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD44—hematologic cancer	9.35e-06	0.000249	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYCS—hematologic cancer	9.34e-06	0.000248	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.28e-06	0.000247	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HSP90AA1—hematologic cancer	9.28e-06	0.000247	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CBL—hematologic cancer	9.22e-06	0.000245	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SDC1—hematologic cancer	9.21e-06	0.000245	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.15e-06	0.000243	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.93e-06	0.000237	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ARNTL—hematologic cancer	8.9e-06	0.000237	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.8e-06	0.000234	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HSP90AA1—hematologic cancer	8.79e-06	0.000234	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.69e-06	0.000231	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACP5—hematologic cancer	8.66e-06	0.00023	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CA9—hematologic cancer	8.66e-06	0.00023	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOR2—hematologic cancer	8.55e-06	0.000227	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT1—hematologic cancer	8.48e-06	0.000226	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.35e-06	0.000222	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.31e-06	0.000221	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—hematologic cancer	8.23e-06	0.000219	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH1—hematologic cancer	8.14e-06	0.000217	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TXN—hematologic cancer	8.05e-06	0.000214	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.05e-06	0.000214	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.05e-06	0.000214	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.96e-06	0.000212	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GRB2—hematologic cancer	7.93e-06	0.000211	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFA—hematologic cancer	7.91e-06	0.00021	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SPHK1—hematologic cancer	7.88e-06	0.00021	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NQO1—hematologic cancer	7.83e-06	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CD44—hematologic cancer	7.83e-06	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KITLG—hematologic cancer	7.8e-06	0.000207	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—hematologic cancer	7.79e-06	0.000207	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.67e-06	0.000204	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT5A—hematologic cancer	7.62e-06	0.000203	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.57e-06	0.000201	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOR1—hematologic cancer	7.56e-06	0.000201	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—hematologic cancer	7.56e-06	0.000201	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN2B—hematologic cancer	7.56e-06	0.000201	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYCS—hematologic cancer	7.41e-06	0.000197	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HSP90AA1—hematologic cancer	7.36e-06	0.000196	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.36e-06	0.000196	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.36e-06	0.000196	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD86—hematologic cancer	7.31e-06	0.000194	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HES1—hematologic cancer	7.21e-06	0.000192	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.18e-06	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NCOR1—hematologic cancer	7.17e-06	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF1—hematologic cancer	7.09e-06	0.000189	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FOXO1—hematologic cancer	6.99e-06	0.000186	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFRB—hematologic cancer	6.97e-06	0.000185	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NUP98—hematologic cancer	6.95e-06	0.000185	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFRA—hematologic cancer	6.87e-06	0.000183	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCG—hematologic cancer	6.84e-06	0.000182	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAK1—hematologic cancer	6.84e-06	0.000182	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.75e-06	0.000179	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.75e-06	0.000179	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NUP214—hematologic cancer	6.7e-06	0.000178	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—hematologic cancer	6.68e-06	0.000178	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.63e-06	0.000176	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.63e-06	0.000176	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.56e-06	0.000175	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTR—hematologic cancer	6.56e-06	0.000175	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—hematologic cancer	6.53e-06	0.000174	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ENO2—hematologic cancer	6.44e-06	0.000171	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—hematologic cancer	6.34e-06	0.000169	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.32e-06	0.000168	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—hematologic cancer	6.32e-06	0.000168	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HLA-A—hematologic cancer	6.32e-06	0.000168	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.24e-06	0.000166	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—hematologic cancer	6.18e-06	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFB—hematologic cancer	6.17e-06	0.000164	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.15e-06	0.000163	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SDC1—hematologic cancer	6.1e-06	0.000162	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TSC2—hematologic cancer	6.03e-06	0.00016	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—hematologic cancer	6e-06	0.00016	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOR1—hematologic cancer	6e-06	0.00016	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.89e-06	0.000157	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.83e-06	0.000155	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR3—hematologic cancer	5.8e-06	0.000154	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.75e-06	0.000153	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—hematologic cancer	5.62e-06	0.000149	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.5e-06	0.000146	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BAD—hematologic cancer	5.5e-06	0.000146	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOTCH1—hematologic cancer	5.44e-06	0.000145	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD80—hematologic cancer	5.33e-06	0.000142	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KIT—hematologic cancer	5.32e-06	0.000142	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—hematologic cancer	5.31e-06	0.000141	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTPN11—hematologic cancer	5.23e-06	0.000139	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CREBBP—hematologic cancer	5.21e-06	0.000138	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NQO1—hematologic cancer	5.19e-06	0.000138	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CD44—hematologic cancer	5.19e-06	0.000138	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.08e-06	0.000135	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CREB1—hematologic cancer	5.07e-06	0.000135	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—hematologic cancer	5e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6R—hematologic cancer	4.94e-06	0.000131	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—hematologic cancer	4.94e-06	0.000131	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CREBBP—hematologic cancer	4.94e-06	0.000131	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYCS—hematologic cancer	4.91e-06	0.000131	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.88e-06	0.00013	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—hematologic cancer	4.87e-06	0.00013	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAP2K1—hematologic cancer	4.71e-06	0.000125	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—hematologic cancer	4.68e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.68e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3R1—hematologic cancer	4.66e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF2—hematologic cancer	4.48e-06	0.000119	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—hematologic cancer	4.46e-06	0.000119	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3R1—hematologic cancer	4.42e-06	0.000118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.39e-06	0.000117	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.33e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.3e-06	0.000114	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAK2—hematologic cancer	4.29e-06	0.000114	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—hematologic cancer	4.19e-06	0.000112	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.19e-06	0.000111	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CREBBP—hematologic cancer	4.13e-06	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.1e-06	0.000109	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTOR—hematologic cancer	4.08e-06	0.000108	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—hematologic cancer	4.08e-06	0.000108	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—hematologic cancer	4.07e-06	0.000108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.98e-06	0.000106	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.98e-06	0.000106	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—hematologic cancer	3.92e-06	0.000104	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—hematologic cancer	3.87e-06	0.000103	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—hematologic cancer	3.83e-06	0.000102	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—hematologic cancer	3.72e-06	9.89e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3R1—hematologic cancer	3.7e-06	9.84e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—EP300—hematologic cancer	3.55e-06	9.43e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—hematologic cancer	3.53e-06	9.4e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—hematologic cancer	3.52e-06	9.37e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.51e-06	9.35e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—hematologic cancer	3.42e-06	9.09e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EP300—hematologic cancer	3.36e-06	8.94e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SRC—hematologic cancer	3.27e-06	8.69e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—hematologic cancer	3.15e-06	8.38e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NRAS—hematologic cancer	3.14e-06	8.36e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.1e-06	8.24e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—hematologic cancer	3.01e-06	8.01e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.95e-06	7.85e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—hematologic cancer	2.95e-06	7.85e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—hematologic cancer	2.93e-06	7.79e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—hematologic cancer	2.92e-06	7.77e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—EP300—hematologic cancer	2.82e-06	7.49e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.74e-06	7.28e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—hematologic cancer	2.71e-06	7.2e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.62e-06	6.98e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.6e-06	6.9e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—hematologic cancer	2.56e-06	6.81e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—hematologic cancer	2.49e-06	6.61e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.45e-06	6.52e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—hematologic cancer	2.3e-06	6.12e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.26e-06	6.02e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—hematologic cancer	2.2e-06	5.86e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—hematologic cancer	2.14e-06	5.7e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.08e-06	5.54e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—hematologic cancer	2.03e-06	5.4e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—hematologic cancer	1.95e-06	5.2e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—EP300—hematologic cancer	1.86e-06	4.96e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—hematologic cancer	1.7e-06	4.52e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.38e-06	3.67e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—hematologic cancer	1.13e-06	3e-05	CbGpPWpGaD
